Published in
Elsevier, Lung Cancer, (149), p. 46-52, 2020
DOI: 10.1016/j.lungcan.2020.09.003
Links
Tools
Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study
Journal article published in 2020 by
Jonathan W. Goldman,
Marina Chiara Garassino,
Yuanbin Chen,
Mustafa Özgüroğlu 
,
Mikhail Dvorkin,
Dmytro Trukhin,
Galina Statsenko,
Oleksandr Voitko,
Libor Havel,
Katsuyuki Hotta,
Artem Poltoratskiy,
Jun Ho Ji,
György Losonczy,
Maximilian J. Hochmair,
Niels Reinmuth
and other authors.
,
Mikhail Dvorkin,
Dmytro Trukhin,
Galina Statsenko,
Oleksandr Voitko,
Libor Havel,
Katsuyuki Hotta,
Artem Poltoratskiy,
Jun Ho Ji,
György Losonczy,
Maximilian J. Hochmair,
Niels Reinmuth
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 